首页> 外文OA文献 >Cutting-Edge Technology for Rapid Bedside Assessment of Capillary Refill Time for Early Diagnosis and Resuscitation of Sepsis
【2h】

Cutting-Edge Technology for Rapid Bedside Assessment of Capillary Refill Time for Early Diagnosis and Resuscitation of Sepsis

机译:快速床边评估毛细血管再灌注时间的尖端技术,术后早期诊断和复苏

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Sepsis currently affects over 30 million people globally with a mortality rate of ~30%. Prompt Emergency Department diagnosis and initiation of resuscitation improves outcomes; data has found an 8% increase in mortality for every hour delay in diagnosis. Once sepsis is recognized, the current Surviving Sepsis Guidelines for adult patients mandate the initiation of antibiotics within 3 h of emergency department triage as well as 30 milliliters per kilogram of intravenous fluids. While these are important parameters to follow, many emergency departments fail to meet these goals for a variety of reasons including turnaround on blood tests such as the serum lactate that may be delayed or require expensive laboratory equipment. However, patients routinely have vital signs assessed and measured in triage within 30 min of presentation. This creates a unique opportunity for implementation point for cutting-edge technology to significantly reduce the time to diagnosis of potentially septic patients allowing for earlier initiation of treatment. In addition to the practical and clinical difficulties with early diagnosis of sepsis, recent clinical trials have shown higher morbidity and mortality when septic patients are over-resuscitated. Technology allowing more real time monitoring of a patient's physiologic responses to resuscitation may allow for more individualized care in emergency department and critical care settings. One such measure at the bedside is capillary refill. This has shown favor in the ability to differentiate subsets of patients who may or may not need resuscitation and interpreting blood values more accurately (1, 2). This is a well-recognized measure of distal perfusion that has been correlated to sepsis outcomes. This physical exam finding is performed routinely, however, there is significant variability in the measurement based on who is performing it. Therefore, technology allowing rapid, objective, non-invasive measurement of capillary refill could improve sepsis recognition compared to algorithms that require lab tests included lactate or white blood count. This manuscript will discuss the broad application of capillary refill to resuscitation care and sepsis in particular for adult patients but much can be applied to pediatrics as well. The authors will then introduce a new technology that has been developed through a problem-based innovation approach to allow clinicians rapid assessment of end-organ perfusion at the bedside or emergency department triage and be incorporated into the electronic medical record. Future applications for identifying patient decompensation in the prehospital and home environment will also be discussed. This new technology has 3 significant advantages: [1] the use of reflected light technology for capillary refill assessment to provide deeper tissue penetration with less signal-to-noise ratio than transmitted infrared light, [2] the ability to significantly improve clinical outcomes without large changes to clinical workflow or provider practice, and [3] it can be used by individuals with minimal training and even in low resource settings to increase the utility of this technology. It should be noted that this perspective focuses on the utility of capillary refill for sepsis care, but it could be considered the next standard of care vital sign for assessment of end-organ perfusion. The ultimate goal for this sensor is to integrate it into existing monitors within the healthcare system.
机译:脓毒症目前影响超过3000万人,并死亡率约为30%。提示急诊部门诊断和重新启动提高了结果;数据已发现每小时诊断时死亡率增加8%。一旦败血症被认识到,目前存活的成人患者的败血症指南要求在急诊部门3小时内授权抗生素的启动,以及每公斤静脉内液体的30毫升。虽然这些是重要的参数,但许多急诊部门因各种原因而无法满足这些目标,包括血液试验(例如可能被延迟或需要昂贵的实验室设备)的血清乳液的转变。然而,患者在介绍30分钟内,常规在分类中进行评估和测量的重要标志。这为尖端技术创造了一个独特的机会,以显着减少诊断潜在脓毒症患者的时间,允许早期的治疗开始。除了早期诊断败血症的实用和临床困难之外,最近的临床试验表明,当脓毒症患者过度复苏时,临床试验表现出较高的发病率和死亡率。技术允许更实时监测患者对复苏的生理反应可能允许在急诊部和关键护理环境中进行更个性化的护理。床边的一个这样的措施是毛细管补充。这表明了对分化可能或可能不需要重新刺除和更准确地解释血值(1,2)的患者的亚群的能力。这是一种良好的远端灌注度量,其与败血症结果相关。然而,该物理检查发现是经常执行的,但是,基于谁执行它的测量存在显着的变化。因此,与需要实验室测试包括乳酸或白血分量的算法相比,技术允许快速,目的,无侵入性测量的技术可以提高败血症识别。该手稿将讨论毛细管补充的广泛应用,特别是对成年患者的复苏护理和败血症,但也可以应用于儿科。然后,作者将介绍一项新技术,通过基于问题的创新方法制定,允许临床医生在床边或急诊部门的终端器灌注进行快速评估,并将其纳入电子病历中。还将讨论用于识别患者在预讨论和家庭环境中识别患者失代偿的应用。这项新技术具有3个显着优势:[1]使用反射光技术的毛细管再填充评估,提供更深入的组织渗透,具有比传递的红外光的信噪比较少,[2]能够显着改善临床结果的能力对临床工作流程或提供商练习的大型变化,以及[3]它可以由具有最小培训的个人使用,即使在低资源设置中以增加该技术的效用。应当注意,这种观点侧重于毛细血管灌注毛细血管保健的效用,但可以考虑评估末端器官灌注的下一个护理生命符号标准。该传感器的最终目标是将其集成到医疗保健系统内的现有监视器中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号